Workflow
QIAGEN(QGEN)
icon
Search documents
QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down
ZACKS· 2026-02-06 14:10
Key Takeaways QGEN posted Q4 adjusted EPS of 62 cents, in line with estimates, while revenues rose 3.7% year over year.QIAGEN saw strength in Sample Technologies and Diagnostic Solutions, offset by a decline in PCR revenues.QGEN reported margin pressure, with adjusted operating margin falling 429 bps amid higher costs.QIAGEN N.V.’s (QGEN)  fourth-quarter 2025 adjusted earnings per share (EPS) were 62 cents, the same at the constant exchange rate (CER). The reported figure increased 1.6% on a year-over-year ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Transcript
2026-02-05 15:32
Qiagen (NYSE:QGEN) Q4 2025 Earnings call February 05, 2026 09:30 AM ET Company ParticipantsDaniel Wendorff - VP and Head of Investor RelationsRoland Sackers - CFOThierry Bernard - CEOConference Call ParticipantsAisyah Noor - AnalystCasey Woodring - AnalystDan Brennan - AnalystDoug Schenkel - AnalystHarry Gillis - AnalystJack Meehan - AnalystKavya Deshpande - AnalystMichael Ryskin - AnalystOdysseas Manesiotis - AnalystTycho Peterson - AnalystOperatorLadies and gentlemen, thank you for standing by. I am Katie ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Transcript
2026-02-05 15:32
Qiagen (NYSE:QGEN) Q4 2025 Earnings call February 05, 2026 09:30 AM ET Company ParticipantsDaniel Wendorff - VP and Head of Investor RelationsRoland Sackers - CFOThierry Bernard - CEOConference Call ParticipantsAisyah Noor - AnalystCasey Woodring - AnalystDan Brennan - AnalystDoug Schenkel - AnalystHarry Gillis - AnalystJack Meehan - AnalystKavya Deshpande - AnalystMichael Ryskin - AnalystOdysseas Manesiotis - AnalystTycho Peterson - AnalystOperatorLadies and gentlemen, thank you for standing by. I am Katie ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Transcript
2026-02-05 15:30
Qiagen (NYSE:QGEN) Q4 2025 Earnings call February 05, 2026 09:30 AM ET Speaker7Ladies and gentlemen, thank you for standing by. I am Katie, your call operator. Welcome, and thank you for joining QIAGEN's fourth quarter 2025 earnings conference call webcast. At this time, all participants are in listen-only mode. Please be advised this call is being recorded at QIAGEN's request and will be made available on their internet site. The prepared remarks will be followed by a question-and-answer session. If you wo ...
QIAGEN(QGEN) - 2025 Q4 - Earnings Call Presentation
2026-02-05 14:30
Q4 and FY 2025 results Continuously delivering solid profitable growth February 4, 2026 Forward looking and intended use statements Safe Harbor Statement: Certain statements contained in this presentation may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These statements can be identified by the use of forward-looking terminology such as "believe", "hope", "pl ...
Qiagen (QGEN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2026-02-05 01:31
Qiagen (QGEN) reported $540.42 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 3.7%. EPS of $0.62 for the same period compares to $0.64 a year ago.The reported revenue represents a surprise of +2.36% over the Zacks Consensus Estimate of $527.96 million. With the consensus EPS estimate being $0.62, the EPS surprise was +0.83%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...
Qiagen (QGEN) Meets Q4 Earnings Estimates
ZACKS· 2026-02-04 23:56
分组1 - Qiagen reported quarterly earnings of $0.62 per share, matching the Zacks Consensus Estimate, and showing a slight decrease from $0.64 per share a year ago, with an earnings surprise of +0.83% [1] - The company achieved revenues of $540.42 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 2.36%, and up from $521.2 million year-over-year [2] - Qiagen has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [2] 分组2 - The stock has increased approximately 9.6% since the beginning of the year, outperforming the S&P 500, which gained 1.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.61 on revenues of $512.6 million, and for the current fiscal year, it is $2.61 on revenues of $2.21 billion [7] - The Medical - Biomedical and Genetics industry, to which Qiagen belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook [8]
Earnings Preview: Qiagen (QGEN) Q4 Earnings Expected to Decline
ZACKS· 2026-01-28 16:06
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Qiagen despite higher revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - Qiagen is expected to report quarterly earnings of $0.61 per share, reflecting a year-over-year decrease of 4.7% [3]. - Revenue is projected to be $527.96 million, which is an increase of 1.3% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.29% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Qiagen is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.34% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with positive readings being more predictive [9][10]. - Qiagen's current Zacks Rank is 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Qiagen exceeded the expected earnings of $0.61 per share by delivering $0.64, resulting in a surprise of +4.92% [13]. - Over the past four quarters, Qiagen has beaten consensus EPS estimates twice [14]. Market Sentiment - Despite the potential for an earnings beat, other factors may influence stock movement, and a positive earnings surprise does not guarantee a stock price increase [15][17].
Qiagen: Takeover Optionality With A High-Quality Consumables Platform (NYSE:QGEN)
Seeking Alpha· 2026-01-27 13:00
Group 1 - The article does not provide any specific insights or analysis related to companies or industries, focusing instead on the author's credentials and disclosures [1][2][3]
Qiagen Explores Possible Sale After New Buyer Talks: Report
Benzinga· 2026-01-21 13:11
German life sciences tools company Qiagen N.V. (NYSE:QGEN) is reportedly reviewing strategic options, including a potential sale, as renewed takeover interest emerges.The European molecular diagnostics company has engaged advisers while its supervisory board evaluates early-stage approaches from potential suitors, Bloomberg reported on Tuesday, signaling a possible shift after several failed attempts to strike a deal in recent years.Citing people with knowledge of the discussions, the report highlighted tha ...